Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients

Fig. 5

Demethylation at enhancer significantly negatively correlated with MCM2 mRNA expression. A Diagram showing the CpG islands in the promoter region of human MCM2 gene. B Heatmap showing overall methylation patterns in the DNA sequence of human MCM2 gene. C Correlation heatmap visualizing the relationship between MCM2 mRNA expression and the methylation level of CpG site at MCM2 promoter region. Dā€“F Scatter plot showing that MCM2 mRNA expression significantly negatively correlated with the methylation level of MCM2 enhancer region (cg08889930) in HCC patients from 3 independent datasets. G MCM2 mRNA expression in Huh7 cells significantly increased after decitabine treatment **** pā€‰<ā€‰0.0001, based on ANOVA. H MCM2 mRNA expression in Huh7 cells significantly reduced after CPI-455 treatment. **** pā€‰<ā€‰0.0001, based on ANOVA. Iā€“J Representative immunoblot of HCC cells (Huh7) lysates showing that decitabine increased MCM2 protein expression and CPI-455 attenuated MCM2 protein expression. TCGA, The Cancer Genome Atlas; ANOVA, analysis of variance; HCC, hepatocellular carcinoma

Back to article page